Cargando…
Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101883/ https://www.ncbi.nlm.nih.gov/pubmed/36907912 http://dx.doi.org/10.1007/s00277-022-04997-3 |
| _version_ | 1785025597535158272 |
|---|---|
| author | Ding, Kai Liu, Zhaoyun Ren, Yue Liu, Hui Fu, Rong |
| author_facet | Ding, Kai Liu, Zhaoyun Ren, Yue Liu, Hui Fu, Rong |
| author_sort | Ding, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10101883 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101018832023-04-15 Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients Ding, Kai Liu, Zhaoyun Ren, Yue Liu, Hui Fu, Rong Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2023-03-13 2023 /pmc/articles/PMC10101883/ /pubmed/36907912 http://dx.doi.org/10.1007/s00277-022-04997-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter to the Editor Ding, Kai Liu, Zhaoyun Ren, Yue Liu, Hui Fu, Rong Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title | Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title_full | Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title_fullStr | Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title_full_unstemmed | Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title_short | Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| title_sort | use of roxadustat (fg-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101883/ https://www.ncbi.nlm.nih.gov/pubmed/36907912 http://dx.doi.org/10.1007/s00277-022-04997-3 |
| work_keys_str_mv | AT dingkai useofroxadustatfg4592inruxolitinibtreatmentrelatedanemiaoftwomyelofibrosispatients AT liuzhaoyun useofroxadustatfg4592inruxolitinibtreatmentrelatedanemiaoftwomyelofibrosispatients AT renyue useofroxadustatfg4592inruxolitinibtreatmentrelatedanemiaoftwomyelofibrosispatients AT liuhui useofroxadustatfg4592inruxolitinibtreatmentrelatedanemiaoftwomyelofibrosispatients AT furong useofroxadustatfg4592inruxolitinibtreatmentrelatedanemiaoftwomyelofibrosispatients |